UK Parliament / Open data

Medicines and Medical Devices Bill

Moved by

Lord Bethell

72: Clause 43, page 26, line 13, after “Part” insert “A1,”

Member’s explanatory statement

This amendment is consequential on the amendments in the Minister’s name inserting a new Part relating to the Commissioner for Patient Safety. It requires the Secretary of State to carry out a public consultation before making regulations about the Commissioner.

73: Clause 43, page 26, line 22, leave out “1(2) and (3), 9(2) and (3) or 14(2) and (3)” and insert “1, 9 or 14”

Member’s explanatory statement

This amendment would require a consultation in relation to regulations under Clause 1, 9 or 14 to include a summary of the assessment of the person making the regulations of all matters mentioned in Clause 1, 9 or 14 (as the case may be), including new subsections (3A), (3A) and (4) inserted by amendments in the Minister’s name into Clauses 1, 9 and 14 respectively (overall assessment of risk-benefit analysis).

74: Clause 43, page 26, line 39, leave out from “to” to “, the” on line 40 and insert “any other regulations”

Member’s explanatory statement

This amendment provides for the definition of “relevant authority” to apply in relation to regulations under new Part A1 (the Commissioner for Patient Safety) and the new Clause tabled in the Minister’s name to appear after Clause 18 (advisory committee), as well as in relation to other regulations under Part 1, 2 or 3.

About this proceeding contribution

Reference

809 c971 

Session

2019-21

Chamber / Committee

House of Lords chamber
Back to top